Novacyt SA
NCYT
Company Profile
Business description
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, IT-IS International, Lab21 Products, Corporate, Yourgene Health and Intercompany eliminations. Majority of the revenue is generated from Yourgene Health segment.
Contact
131 Boulevard Carnot
Le Vesinet78110
FRAE: investor.relations@novacyt.co.uk
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
237
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,913.90 | 66.30 | 0.84% |
| CAC 40 | 7,126.02 | 263.00 | 3.83% |
| DAX 40 | 20,562.73 | 891.85 | 4.53% |
| Dow JONES (US) | 39,593.66 | 1,948.07 | 5.17% |
| FTSE 100 | 7,913.25 | 141.73 | -1.76% |
| HKSE | 20,681.78 | 2,168.03 | -9.49% |
| NASDAQ | 16,387.31 | 1,119.40 | 7.33% |
| Nikkei 225 | 34,609.00 | 828.42 | 2.45% |
| NZX 50 Index | 12,082.65 | 118.78 | -0.97% |
| S&P 500 | 5,268.05 | 188.85 | -3.46% |
| S&P/ASX 200 | 7,709.60 | 41.80 | 0.55% |
| SSE Composite Index | 3,223.64 | 36.83 | 1.16% |